A Randomized Double-Blind Placebo Controlled Trial Evaluating the Safety and Efficacy of Etanercept 25 mg Twice Weekly in Subjects with Moderate to Severe Persistent Asthma

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-003778-27

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To assess the efficacy and safety of etanercept 25 mg twice weekly in subjects with moderate to severe persistent asthma


Critère d'inclusion

  • Moderate to severe asthmatics